Key details
Sponsor
Steno Diabetes Center Copenhagen
Collaborators
Novo Nordisk A/S, University of Leeds
Enrollment target
~45 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Last updated December 2024